Short-term outcomes of COVID-19 in pregnant women unvaccinated for SARS-CoV-2 in the first, second, and third trimesters
a retrospective study
Palavras-chave:
COVID-19, SARS-CoV-2, Pregnancy, Intensive care units, neonatalResumo
BACKGROUND: Coronavirus disease 2019 (COVID-19) may be asymptomatic or symptomatic in pregnant women. Compared to non-pregnant reproductive-aged women, symptomatic individuals appear to have a higher risk of acquiring severe illness sequelae. OBJECTIVES: We assessed the clinical and laboratory characteristics and outcomes of pregnant COVID-19 patients unvaccinated for severe acute respiratory syndrome coronavirus 2 according to the trimester of pregnancy. DESIGN AND SETTING: This was a retrospective observational study conducted in a tertiary-level hospital in Turkey. METHODS: This retrospective study reviewed the clinical and laboratory characteristics and outcomes of 445 pregnant COVID-19 patients hospitalized during the first, second, and third trimesters of pregnancy and 149 other pregnant women as controls in a tertiary center from April 2020 to December 2021. All participants were unvaccinated. RESULTS: Overall, the study groups were comparable in terms of baseline clinical pregnancy characteristics. There was no clear difference among the study participants with COVID-19 in the first, second, and third trimesters of pregnancy. However, a considerably high number of clinical and laboratory findings revealed differences that were consistent with the inflammatory nature of the disease. CONCLUSIONS: The study results reveal the importance of careful follow-up of hospitalized cases as a necessary step by means of regular clinical and laboratory examinations in pregnant COVID-19 patients. With further studies, after implementing vaccination programs for COVID-19 in pregnant women, these data may help determine the impact of vaccination on the outcomes of pregnant COVID-19 patients.
Downloads
Referências
Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19(3):141-54. Erratum in: Nat Rev Microbiol. 2022;20(5):315. PMID: 33024307; https://doi.org/10.1038/s41579-020-00459-7.
Proal AD, VanElzakker MB. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front Microbiol. 2021;12:698169. PMID: 34248921; https://doi.org/10.3389/fmicb.2021.698169.
AlTakarli NS. China’s Response to the COVID-19 Outbreak: A Model for Epidemic Preparedness and Management. Dubai Med J. 2020;3:44-9. https://doi.org/10.1159/000508448.
Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-42. PMID: 32091533; https://doi.org/10.1001/jama.2020.2648.
The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020. China CDC Wkly. 2020;2(8):113-22. PMID: 34594836.
Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9. Erratum in: JAMA. 2021;325(11):1113. PMID: 32031570; https://doi.org/10.1001/jama.2020.1585.
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62. Erratum in: Lancet. 2020;395(10229):1038. PMID: 32171076; https://doi.org/10.1016/s0140-6736(20)30566-3.
Bhatraju PK, Ghassemieh BJ, Nichols M, et al. Covid-19 in Critically Ill Patients in the Seattle Region - Case Series. N Engl J Med. 2020;382(21):2012-22. PMID: 32227758; https://doi.org/10.1056/nejmoa2004500.
Racicot K, Mor G. Risks associated with viral infections during pregnancy. J Clin Invest. 2017;127(5):1591-9. PMID: 28459427; https://doi.org/10.1172/jci87490.
Bloise E, Zhang J, Nakpu J, et al. Expression of severe acute respiratory syndrome coronavirus 2 cell entry genes, angiotensin-converting enzyme 2 and transmembrane protease serine 2, in the placenta across gestation and at the maternal-fetal interface in pregnancies complicated by preterm birth or preeclampsia. Am J Obstet Gynecol. 2021;224(3):298.e1-298.e8. PMID: 32853537; https://doi.org/10.1016/j.ajog.2020.08.055.
Marín R, Pujol FH, Rojas D, Sobrevia L. SARS- CoV-2 infection and oxidative stress in early-onset preeclampsia. Biochim Biophys Acta Mol Basis Dis. 2022;1868(3):166321. PMID: 34920081; https://doi.org/10.1016/j.bbadis.2021.166321.
Metz TD, Clifton RG, Hughes BL, et al. Disease Severity and Perinatal Outcomes of Pregnant Patients With Coronavirus Disease 2019 (COVID-19). Obstet Gynecol. 2021;137(4):571-80. PMID: 33560778; https://doi.org/10.1097/aog.0000000000004339.
Liu H, Wang LL, Zhao SJ, et al. Why are pregnant women susceptible to COVID-19? An immunological viewpoint. J Reprod Immunol. 2020;139:103122. PMID: 32244166; https://doi.org/10.1016/j. jri.2020.103122.
Kakaraparthi VN, Alshahrani MS, Reddy RS, et al. Anxiety, depression, worry, and stress-related perceptions among antenatal women during the COVID-19 pandemic: Single group repeated measures design. Indian J Psychiatry. 2022;64(1):64-72. PMID: 35400735; https://doi.org/10.4103%2Findianjpsychiatry.indianjpsychiatry_1359_20.
Boelig RC, Saccone G, Bellussi F, Berghella V. MFM guidance for COVID-19. Am J Obstet Gynecol MFM. 2020;2(2):100106. PMID: 32363335; https://doi.org/10.1016/j.ajogmf.2020.100106.
Bozkurt F, Çoşkun Ö, Yeleç S, et al. Comparison of the Clinical and Laboratory Findings in COVID-19 Positive Pregnants without Comorbidity. Turk J Med Sci. 2021. PMID: 34233388; https://doi.org/10.3906/sag-2105-116. Epub ahead of print.
Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708-20. PMID: 32109013; https://doi.org/10.1056/nejmoa2002032.
Valapala VNG, Dasari N, Kolli VK, Mandapaka M. Clinical and biochemical profile of COVID-19 patients admitted in a tertiary care hospital in Visakhapatnam, India during post unlock 2.0 - a retrospective study. J Med Life. 2022;15(2):264-8. PMID: 35419104; https://doi.org/10.25122/jml-2021-0341.
Suryawanshi SY, Priya S, Sinha SS, et al. Dynamic profile and clinical implications of hematological and immunological parameters in COVID-19 patients. A retrospective study. J Family Med Prim Care. 2021;10(7):2518-23. PMID: 34568129; https://doi.org/10.4103/jfmpc.jfmpc_2400_20.
Sun G, Zhang Y, Liao Q, Cheng Y. Blood Test Results of Pregnant COVID-19 Patients: An Updated Case-Control Study. Front Cell Infect Microbiol. 2020;10:560899. PMID: 33117727; https://doi.org/10.3389/fcimb.2020.560899.
Chen L, Li Q, Zheng D, et al. Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China. N Engl J Med. 2020;382(25):e100. PMID: 32302077; https://doi.org/10.1056/nejmc2009226.
Liu D, Li L, Wu X, et al. Pregnancy and Perinatal Outcomes of Women With Coronavirus Disease (COVID-19) Pneumonia: A Preliminary Analysis. AJR Am J Roentgenol. 2020;215(1):127-32. Erratum in: AJR Am J Roentgenol. 2020;215(1):262. PMID: 32186894; https://doi.org/10.2214/ajr.20.23072.
Larsen JB, Pasalic L, Hvas AM. Platelets in Coronavirus Disease 2019. Semin Thromb Hemost. 2020;46(7):823-5. PMID: 32356294; https://doi.org/10.1055/s-0040-1710006.
Xu P, Zhou Q, Xu J. Mechanism of thrombocytopenia in COVID-19 patients. Ann Hematol. 2020;99(6):1205-8. PMID: 32296910; https://doi.org/10.1007/s00277-020-04019-0.
Ciavarella A, Erra R, Abbattista M, et al. Hemostasis in pregnant women with COVID-19. Int J Gynaecol Obstet. 2021;152(2):268-9. PMID: 33245783; https://doi.org/10.1002/ijgo.13499.
Cai Q, Huang D, Yu H, et al. COVID-19: Abnormal liver function tests. J Hepatol. 2020;73(3):566-74. PMID: 32298767; https://doi.org/10.1016/j.jhep.2020.04.006.
Bertolini A, van de Peppel IP, Bodewes FAJA, et al. Abnormal Liver Function Tests in Patients With COVID-19: Relevance and Potential Pathogenesis. Hepatology. 2020;72(5):1864-72. PMID: 32702162; https://doi.org/10.1002/hep.31480.
Alqahtani SA, Schattenberg JM. Liver injury in COVID-19: The current evidence. United European Gastroenterol J. 2020;8(5):509-19. PMID: 32450787; https://doi.org/10.1177/2050640620924157.
Chmielewska B, Barratt I, Townsend R, et al. Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis. Lancet Glob Health. 2021;9(6):e759-e772. PMID: 33811827; https://doi.org/10.1016/s2214-109x(21)00079-6.
Khalil A, von Dadelszen P, Draycott T, et al. Change in the Incidence of Stillbirth and Preterm Delivery During the COVID-19 Pandemic. JAMA. 2020;324(7):705-6. PMID: 32648892; https://doi.org/10.1001/jama.2020.12746.
Knight M, Bunch K, Vousden N, et al. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study. BMJ. 2020;369:m2107. PMID: 32513659; https://doi.org/10.1136/bmj.m2107.
Antoun L, Taweel NE, Ahmed I, Patni S, Honest H. Maternal COVID-19 infection, clinical characteristics, pregnancy, and neonatal outcome: A prospective cohort study. Eur J Obstet Gynecol Reprod Biol. 2020;252:559-62. PMID: 32732059; https://doi.org/10.1016/j.ejogrb.2020.07.008.
Simon E, Gouyon JB, Cottenet J, et al. Impact of SARS-CoV-2 infection on risk of prematurity, birthweight and obstetric complications: A multivariate analysis from a nationwide, population-based retrospective cohort study. BJOG. 2022;129(7):1084-94. PMID: 35253329; https://doi.org/10.1111/1471-0528.17135.
Tunç Ş, Göklü MR, Oğlak SC. COVID-19 in pregnant women: An evaluation of clinical symptoms and laboratory parameters based on the 3 trimesters. Saudi Med J. 2022;43(4):378-85. PMID: 35414616; https://doi.org/10.15537/smj.2022.43.4.20210904.
Downloads
Publicado
Como Citar
Edição
Seção
Licença

Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.